Anthony P. Davenport, Stephen P. H. Alexander, Joanna L. Sharman, Adam J. Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig, Jean Philippe Pin, Michael Spedding and Anthony J. Harmar
Eliot H. Ohlstein, ASSOCIATE EDITOR, Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom (S.P.H.A.); The University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom (J.L.S., A.J.P., H.E.B., A.E.M., W.C.L., C.P.M., A.J.H.); Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Department of Molecular Pharmacology, Institute of Functional Genomics, CNRS UMR5203, Universities Montpellier, Montpellier, France (J.P.P.); and Les Laboratoires Servier, Suresnes, France (M.S.)
